-
The report recently released by Consumer Reports (CR) on infection rates in health care facilities highlights the importance of transparent public reporting, but a national system is needed to replace the variety of state approaches, the Society for Healthcare Epidemiology of America (SHEA) said in a statement.
-
All the caveats and concerns about whether infection rate disclosures will lead to unintended consequences were more or less rendered moot. For starters, there's a guy on the CR cover snowboarding out of giant TV screen.
-
-
Given that some trace the very founding of hospital infection prevention programs back to the first volleys in the longstanding battle with multidrug-resistant organisms (MDROs), it comes as little surprise that The Joint Commission has made these bugs the focus of a National Patient Goal for 2010.
-
The Joint Commission has dropped a controversial infection prevention patient safety goal that recommended sentinel event investigations of unanticipated patient deaths and serious injuries due to health care-associated infections (HAIs).
-
A proud "Aussie" is the 2010 president of the Association for Professionals in Infection Control and Epidemiology (APIC), putting an international face on an organization that clearly wants to expand its global reach.
-
An estimated 430,000 children worldwide became infected with HIV in 2008, mostly through birth or breastfeeding from an HIV-infected mother.
-
AIDS-defining conditions and risks are different for HIV-positive patients who are older, usually defined as age 50 and above, experts say.
-
Frailty is not a diagnosis that typically comes to mind when clinicians examine HIV patients, but with increasing numbers of older people being diagnosed or younger patients growing old with the disease, it should be on HIV clinicians' radar.
-
On Jan. 29, 2009, the Food and Drug Administration (FDA) approved revisions to the lopinavir/ritonavir (Kaletra®) package insert to include drug-drug interaction information for concurrent lopinavir/ritonavir administration with inhaled medicines such as salmeterol or salmeterol in combination with fluticasone propionate (Serevent®, Advair®) and sildenafil (Revatio®).